| Literature DB >> 25099447 |
Al B Benson, Michael I D'Angelica, Thomas A Abrams, Chandrakanth Are, P Mark Bloomston, Daniel T Chang, Bryan M Clary, Anne M Covey, William D Ensminger, Renuka Iyer, R Kate Kelley, David Linehan, Mokenge P Malafa, Steven G Meranze, James O Park, Timothy Pawlik, James A Posey, Courtney Scaife, Tracey Schefter, Elin R Sigurdson, G Gary Tian, Jean-Nicolas Vauthey, Alan P Venook, Yun Yen, Andrew X Zhu, Karin G Hoffmann, Nicole R McMillian, Hema Sundar.
Abstract
Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma), gall bladder, and bile ducts (cholangiocarcinomas). Gallbladder cancer and cholangiocarcinomas are collectively known as biliary tract cancers. Gallbladder cancer is the most common and aggressive type of all the biliary tract cancers. Cholangiocarcinomas are diagnosed throughout the biliary tree and are typically classified as either intrahepatic or extrahepatic cholangiocarcinoma. Extrahepatic cholangiocarcinomas are more common than intrahepatic cholangiocarcinomas. This manuscript focuses on the clinical management of patients with gallbladder cancer and cholangiocarcinomas (intrahepatic and extrahepatic).Entities:
Mesh：
Year: 2014 PMID： 25099447 DOI： 10.6004/jnccn.2014.0112
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908